Saturday 17 October 2026
Export NTRA’s income statement to Excel — free account
Natera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 36.5%, free cash flow fell 174.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
391.98
12.81
−3.16%
Follow NTRA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| (12.54%) | (15.02%) | (14.32%) | (29.02%) | ||
| (8.71%) | (10.41%) | (10.26%) | (18.12%) | ||
ROIC |
(22.34%) | (26.44%) | (27.03%) | (75.81%) | |
Return on Tangible Assets |
(13.51%) | (16.60%) | (16.05%) | (25.51%) | |
Average Days of Receivables |
56.89 | 60.95 | 46.93 | 49.38 | |
Free Cash Flow per Share |
0.59 | 0.74 | 0.80 | 0.77 | |
Free Cash Flow |
84.20 | 104.51 | 109.11 | 106.07 | |
Capital Expenditures |
(144.04) | (106.51) | (106.19) | (88.23) | |
| Other line items | |||||
Cash ROIC |
2.81% | 3.55% | 3.80% | 4.47% | |
Accounts Receivable Turnover |
7.40 | 6.80 | 7.55 | 7.14 | |
Accounts Payable Turnover |
16.80 | 17.19 | 23.88 | 20.70 | |
Inventory Turnover |
13.98 | 14.43 | 14.36 | 13.57 | |
Average Days of Payables |
29.14 | 26.07 | 14.89 | 22.06 | |
Days of Inventory on Hand |
31.16 | 29.55 | 30.73 | 30.67 | |
Tax Rate |
(0.24) | (0.21) | (0.22) | 0.00 | |
Research and Development Expense of Revenue |
29.09% | 28.22% | 27.06% | 27.32% | |
Selling, General and Administrative Expense of Revenue |
46.36% | 49.52% | 51.05% | 52.95% | |
Share Based Compensation of Revenue |
14.09% | 14.86% | 15.37% | 15.77% | |
Interest Coverage |
(75.89) | (81.96) | (76.16) | (80.50) | |
Operating CF/Net income |
(1.19) | (0.93) | (1.03) | (0.63) | |
Depreciation/Fixed assets |
0.21 | 0.20 | 0.18 | 0.18 | |
Capex/Depreciation |
(2.19) | (1.95) | (2.44) | (2.37) | |
Revenue per Share |
18.89 | 17.67 | 16.87 | 15.43 | |
Operating CF per Share |
1.59 | 1.49 | 1.57 | 1.42 | |
Capex per Share |
(1.01) | (0.75) | (0.78) | (0.64) | |
Capex to Sales |
0.05 | 0.04 | 0.05 | 0.04 |
Columns are period end dates